The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / The Search for a Sepsis Signal
Research and Innovations Point of care testing Screening and monitoring Opinion and Personal Narratives Voices in the Community

The Search for a Sepsis Signal

Simon Walker and Cathal McElgunn discuss the diagnostic gaps in sepsis and the biomarker science that could help close them

By Helen Bristow 10/23/2026 Interview 6 min read
  • Full Article
  • Summary
  • Takeaways
  • Scorecard
  • Quiz
  • Poll

Share

5 Key Takeaways
  • 1

    Sepsis is difficult to diagnose because its symptoms are varied and nonspecific, and current blood tests often detect inflammation without identifying a dangerous trajectory.

  • 2

    Blood cultures can identify an organism and guide antibiotic selection, but results may take 48 hours or more, while sepsis can progress rapidly.

  • 3

    Simon Walker and Cathal McElgunn say an earlier sepsis-risk test could complement microbiological testing and help clinicians assess whether to escalate treatment.

  • 4

    Published research suggests that a higher oxidized-to-total PTX3 ratio correlates with more severe sepsis and that the ratio declines as patients improve.

  • 5

    MicrosensDx is developing an immunoassay to distinguish oxidized from nonoxidized PTX3; its antibody pair is in optimization, with the linearity range established.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.